Clinical Trials Logo

Filter by:
NCT ID: NCT03201952 Terminated - Glucose Intolerance Clinical Trials

Examination of the Metabolic Effects of Direct Bile Salt Delivery to the Ileum in Humans

Start date: February 1, 2018
Phase: Phase 1
Study type: Interventional

This project will evaluate distal intestinal bile salt administration in humans by deliving ursodeoxycholic acid (UDCA) into the terminal ileum of subjects with a pre-existing ileostomy and assessing several hormone levels following an oral glucose tolerance test compared to a placebo.

NCT ID: NCT03201809 Terminated - Post-operative Pain Clinical Trials

Comparison of Preoperative Ultrasound Guided Pectoralis Nerve Block Placement Versus Intra-operative Placement: A Prospective Randomized Trial

Start date: September 1, 2016
Phase: N/A
Study type: Interventional

This study investigates the use of post-operative on-Q pain catheters for tissue expander based breast reconstruction, versus conventional ultrasound-guided blocks placed pre-operatively.

NCT ID: NCT03201445 Terminated - Clinical trials for Inflammatory Bowel Disease

Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel Disease

MANTA
Start date: July 11, 2017
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to evaluate the testicular safety of filgotinib in adult males with moderately to severely active inflammatory bowel disease (IBD). Results of this study may be pooled with the results of a separate study being conducted in participants with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, or non-radiographic axial spondyloarthritis (Protocol GLPG0634-CL-227; NCT03926195) with the same objective. The total planned number of participants in both studies combined will be up to approximately 250 participants.

NCT ID: NCT03201250 Terminated - Multiple Myeloma Clinical Trials

Cabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple Myeloma

Start date: February 21, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

In the currently proposed phase I/II study, the investigators aim to treat patients with relapsed and/or relapsed refractory Multiple Myeloma who have progressed on carfilzomib-based therapy with an FDA approved c-MET inhibitor, cabozantinib.

NCT ID: NCT03201042 Terminated - Lyme Disease Clinical Trials

Lyme Test Indication Combinations (LyTIC) Study

LyTIC
Start date: June 8, 2017
Phase:
Study type: Observational

To establish performance of individual tests and combinations of tests (serological, molecular and cellular tests) in early Lyme infection diagnosis

NCT ID: NCT03200548 Terminated - Quality of Life Clinical Trials

Acupressure for Fatigue in Systemic Lupus Erythematosus

AcuSLE
Start date: August 14, 2017
Phase: N/A
Study type: Interventional

Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by involvement of multiple organs with a female to male ratio of 12:1 with the highest incidence reported in women of child bearing age (15-44 years). In general, advances in diagnosis and management have led to significant improvements in outcomes. However, fatigue remains a challenging and prevalent issue for SLE patients. The investigators aim to determine the feasibility of recruiting and conducting acupressure in fatigued persons with lupus; to explore the effect of two distinct acupressure formulas (relaxing and stimulating) plus usual care versus sham acupressure plus usual care and usual care alone on severity and impact of chronic fatigue (as measured by the Brief Fatigue Inventory) as well as quality of life, sleep and pain.

NCT ID: NCT03200522 Terminated - Asthma Clinical Trials

BREATHE-Easy Trial

Start date: October 12, 2017
Phase: N/A
Study type: Interventional

This research is being done to evaluate the feasibility of a prudent versus Western diet feeding study in women with asthma in Baltimore City. The results of this research will provide data to appropriately design a definitive study looking at the differential effects of these two diets on asthma health.

NCT ID: NCT03200093 Terminated - Clinical trials for Clostridium Difficile Infection

Oral Vancomycin for Preventing Clostridium Difficile Recurrence

Start date: June 8, 2017
Phase: Phase 4
Study type: Interventional

This study evaluates the role of oral vancomycin in the prevention of recurrent Clostridium difficile for hospitalized patients receiving systemic antibiotic therapy. Half of participants will receive oral vancomycin daily, while the other half will receive a placebo.

NCT ID: NCT03199963 Terminated - Clinical trials for Mammographic Breast Density

Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue

4WARD
Start date: August 21, 2017
Phase: Phase 3
Study type: Interventional

A study to determine the efficacy of 8 mg/day (4 mg/breast) of BHR-700 gel compared to placebo for reducing breast tissue density in women identified as having dense breast tissue upon analysis of screening mammography. The Primary Study Endpoint being the percent reduction of mammographic breast tissue density on a follow-up mammogram compared to the baseline mammogram after 52 weeks of treatment.

NCT ID: NCT03199404 Terminated - Stroke, Ischemic Clinical Trials

Trevo Aspiration Proximal Flow Control Registry

TRAP
Start date: June 6, 2017
Phase:
Study type: Observational [Patient Registry]

This purpose of this retrospective, single-arm, non-randomized, multi-center study is to collect real-world data on the effectiveness of using the TRAP technique in acute ischemic stroke patients undergoing mechanical thrombectomy.